» Articles » PMID: 38030596

HDAC8-mediated Inhibition of EP300 Drives a Transcriptional State That Increases Melanoma Brain Metastasis

Abstract

Melanomas can adopt multiple transcriptional states. Little is known about the epigenetic drivers of these cell states, limiting our ability to regulate melanoma heterogeneity. Here, we identify stress-induced HDAC8 activity as driving melanoma brain metastasis development. Exposure of melanocytes and melanoma cells to multiple stresses increases HDAC8 activation leading to a neural crest-stem cell transcriptional state and an amoeboid, invasive phenotype that increases seeding to the brain. Using ATAC-Seq and ChIP-Seq we show that increased HDAC8 activity alters chromatin structure by increasing H3K27ac and enhancing accessibility at c-Jun binding sites. Functionally, HDAC8 deacetylates the histone acetyltransferase EP300, causing its enzymatic inactivation. This, in turn, increases binding of EP300 to Jun-transcriptional sites and decreases binding to MITF-transcriptional sites. Inhibition of EP300 increases melanoma cell invasion, resistance to stress and increases melanoma brain metastasis development. HDAC8 is identified as a mediator of transcriptional co-factor inactivation and chromatin accessibility that drives brain metastasis.

Citing Articles

The epigenetic landscape of brain metastasis.

Powell A, Watson L, Luzietti L, Prekovic S, Young L, Vareslija D Oncogene. 2025; .

PMID: 40016470 DOI: 10.1038/s41388-025-03315-1.


Regulation of metastatic organotropism.

Dunbar K, Efe G, Cunningham K, Esquea E, Navaridas R, Rustgi A Trends Cancer. 2024; 11(3):216-231.

PMID: 39732596 PMC: 11903188. DOI: 10.1016/j.trecan.2024.11.012.


Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application.

Chen Y, Liang R, Li Y, Jiang L, Ma D, Luo Q Signal Transduct Target Ther. 2024; 9(1):340.

PMID: 39627201 PMC: 11615378. DOI: 10.1038/s41392-024-02030-9.


Multi-proteomics and interactome dataset of tick-borne encephalitis virus infected host cells.

Sui L, Guo X, Wang W, Xu Y, Zhao Y, Liu Q Sci Data. 2024; 11(1):1280.

PMID: 39587125 PMC: 11589117. DOI: 10.1038/s41597-024-04036-y.


Compressive stresses in cancer: characterization and implications for tumour progression and treatment.

Linke J, Munn L, Jain R Nat Rev Cancer. 2024; 24(11):768-791.

PMID: 39390249 DOI: 10.1038/s41568-024-00745-z.


References
1.
Cho J, Robinson J, Arave R, Burnett W, Kircher D, Chen G . AKT1 Activation Promotes Development of Melanoma Metastases. Cell Rep. 2015; 13(5):898-905. PMC: 4646731. DOI: 10.1016/j.celrep.2015.09.057. View

2.
Karras P, Bordeu I, Pozniak J, Nowosad A, Pazzi C, Van Raemdonck N . A cellular hierarchy in melanoma uncouples growth and metastasis. Nature. 2022; 610(7930):190-198. PMC: 10439739. DOI: 10.1038/s41586-022-05242-7. View

3.
Kim Y, Sheu K, Tsoi J, Abril-Rodriguez G, Medina E, Grasso C . Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti-PD-1 therapy. J Clin Invest. 2021; 131(12). PMC: 8203459. DOI: 10.1172/JCI145859. View

4.
Vries R, Prudenziati M, Zwartjes C, Verlaan M, Kalkhoven E, Zantema A . A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300. EMBO J. 2001; 20(21):6095-103. PMC: 125698. DOI: 10.1093/emboj/20.21.6095. View

5.
Konieczkowski D, Johannessen C, Abudayyeh O, Kim J, Cooper Z, Piris A . A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discov. 2014; 4(7):816-27. PMC: 4154497. DOI: 10.1158/2159-8290.CD-13-0424. View